Company intelligence / Profile preview

Laboratoires Pharmaceutiques Dexo

Osny, France

Ownership: Private
Development stage: Other

Overview

Laboratoires Pharmaceutiques Dexo was a French pharmaceutical company specializing in the development and commercialization of products for rheumatology and dermatology. The company was well-known in the French market for its portfolio of mature brands and niche therapeutic solutions. In 2016, Dexo was acquired by Laboratoire HRA Pharma to strengthen HRA's presence in the French domestic market and diversify its therapeutic offerings. Following the acquisition, Dexo's operations and products were integrated into HRA Pharma, which was subsequently acquired by Perrigo in 2022.

Therapeutic areas: ImmunologyRheumatologyDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Laboratoires Pharmaceutiques Dexo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratoires Pharmaceutiques Dexo.

Explore the full profile